FusionNeoAntigen Logo

Home

Download

Statistics

Examples

Help

Contact

Terms of Use

Center for Computational Systems Medicine
leaf

Fusion Gene and Fusion Protein Summary

leaf

Fusion Amino Acid Sequences (multiple BPs and multiple gene isoforms)

leaf

Fusion Protein Breakpoint Sequences - (for the Screening of the FusionNeoAntigens)

leaf

Potential FusionNeoAntigens in HLA I - (netMHCpan v4.1 + deepHLApan v1.1)

leaf

Potential FusionNeoAntigens in HLA II - (netMHCIIpan v4.1)

leaf

Fusion Breakpoint 14 AA Peptide Structure - (RoseTTAFold)

leaf

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D - (Glide)

leaf

Vaccine Design for the FusionNeoAntigens (RNA/protein sequences)

leaf

Potential target of CAR-T therapy development

leaf

Information on the samples that have these potential fusion neoantigens

leaf

Fusion Protein Targeting Drugs - (Manual Curation)

leaf

Fusion Protein Related diseases - (Manual Curation)

Fusion Protein:PARK7-GNB1

Fusion Gene and Fusion Protein Summary

check button Fusion gene summary
Fusion partner gene informationFusion gene name: PARK7-GNB1
FusionPDB ID: 62768
FusionGDB2.0 ID: 62768
HgeneTgene
Gene symbol

PARK7

GNB1

Gene ID

11315

2782

Gene nameParkinsonism associated deglycaseG protein subunit beta 1
SynonymsDJ-1|DJ1|GATD2|HEL-S-67pMRD42
Cytomap

1p36.23

1p36.33

Type of geneprotein-codingprotein-coding
Descriptionprotein/nucleic acid deglycase DJ-1Parkinson disease (autosomal recessive, early onset) 7epididymis secretory sperm binding protein Li 67pmaillard deglycaseoncogene DJ1parkinson protein 7protein DJ-1protein deglycase DJ-1guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1beta subunit, signal-transducing proteins GS/GIguanine nucleotide binding protein (G protein), beta polypeptide 1testicular tissue protein Li 72transducin beta chain 1
Modification date2020032720200321
UniProtAcc.

Q9BYB4

Main function of 5'-partner protein:
Ensembl transtripts involved in fusion geneENST idsENST00000497113, ENST00000338639, 
ENST00000377488, ENST00000377491, 
ENST00000377493, ENST00000493678, 
ENST00000378609, ENST00000472614, 
Fusion gene scores for assessment (based on all fusion genes of FusionGDB 2.0)* DoF score5 X 5 X 4=10039 X 29 X 13=14703
# samples 648
** MAII scorelog2(6/100*10)=-0.736965594166206
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
log2(48/14703*10)=-4.93693233652239
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
Fusion gene context

PubMed: PARK7 [Title/Abstract] AND GNB1 [Title/Abstract] AND fusion [Title/Abstract]

Fusion neoantigen context

PubMed: PARK7 [Title/Abstract] AND GNB1 [Title/Abstract] AND neoantigen [Title/Abstract]

Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0)PARK7(8022935)-GNB1(1749314), # samples:1
Anticipated loss of major functional domain due to fusion event.
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types
** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10)

check button Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez
PartnerGeneGO IDGO termPubMed ID
HgenePARK7

GO:0006281

DNA repair

28596309

HgenePARK7

GO:0006517

protein deglycosylation

25416785

HgenePARK7

GO:0006517

protein deglycosylation

27903648

HgenePARK7

GO:0009438

methylglyoxal metabolic process

22523093

HgenePARK7

GO:0009438

methylglyoxal metabolic process

27903648

HgenePARK7

GO:0010629

negative regulation of gene expression

22683601

HgenePARK7

GO:0019249

lactate biosynthetic process

22523093

HgenePARK7

GO:0031334

positive regulation of protein complex assembly

24947010

HgenePARK7

GO:0031397

negative regulation of protein ubiquitination

17015834|24899725

HgenePARK7

GO:0032091

negative regulation of protein binding

11477070|16731528|17015834|24899725

HgenePARK7

GO:0032435

negative regulation of proteasomal ubiquitin-dependent protein catabolic process

17015834

HgenePARK7

GO:0032757

positive regulation of interleukin-8 production

21097510

HgenePARK7

GO:0033234

negative regulation of protein sumoylation

16731528

HgenePARK7

GO:0034599

cellular response to oxidative stress

15983381|19703902|20969476|22683601

HgenePARK7

GO:0036471

cellular response to glyoxal

22523093

HgenePARK7

GO:0036526

peptidyl-cysteine deglycation

25416785

HgenePARK7

GO:0036527

peptidyl-arginine deglycation

25416785

HgenePARK7

GO:0036528

peptidyl-lysine deglycation

25416785

HgenePARK7

GO:0036529

protein deglycation, glyoxal removal

25416785

HgenePARK7

GO:0036530

protein deglycation, methylglyoxal removal

25416785

HgenePARK7

GO:0036530

protein deglycation, methylglyoxal removal

27903648

HgenePARK7

GO:0036531

glutathione deglycation

25416785

HgenePARK7

GO:0042743

hydrogen peroxide metabolic process

20969476|24567322

HgenePARK7

GO:0043066

negative regulation of apoptotic process

22523093

HgenePARK7

GO:0043523

regulation of neuron apoptotic process

18711745|20304780

HgenePARK7

GO:0043524

negative regulation of neuron apoptotic process

22511790

HgenePARK7

GO:0045944

positive regulation of transcription by RNA polymerase II

21097510

HgenePARK7

GO:0046295

glycolate biosynthetic process

22523093

HgenePARK7

GO:0050821

protein stabilization

24947010

HgenePARK7

GO:0051444

negative regulation of ubiquitin-protein transferase activity

24899725

HgenePARK7

GO:0060548

negative regulation of cell death

14749723

HgenePARK7

GO:0060765

regulation of androgen receptor signaling pathway

11477070

HgenePARK7

GO:0070301

cellular response to hydrogen peroxide

14749723

HgenePARK7

GO:0106044

guanine deglycation

28596309

HgenePARK7

GO:0106045

guanine deglycation, methylglyoxal removal

28596309

HgenePARK7

GO:0106046

guanine deglycation, glyoxal removal

28596309

HgenePARK7

GO:1900182

positive regulation of protein localization to nucleus

21097510

HgenePARK7

GO:1901215

negative regulation of neuron death

22683601

HgenePARK7

GO:1901671

positive regulation of superoxide dismutase activity

24567322

HgenePARK7

GO:1901984

negative regulation of protein acetylation

22683601

HgenePARK7

GO:1903094

negative regulation of protein K48-linked deubiquitination

21097510

HgenePARK7

GO:1903168

positive regulation of pyrroline-5-carboxylate reductase activity

23743200

HgenePARK7

GO:1903178

positive regulation of tyrosine 3-monooxygenase activity

19703902

HgenePARK7

GO:1903181

positive regulation of dopamine biosynthetic process

19703902

HgenePARK7

GO:1903189

glyoxal metabolic process

22523093

HgenePARK7

GO:1903200

positive regulation of L-dopa decarboxylase activity

19703902

HgenePARK7

GO:1903202

negative regulation of oxidative stress-induced cell death

16632486

HgenePARK7

GO:1903208

negative regulation of hydrogen peroxide-induced neuron death

15983381|24947010

HgenePARK7

GO:1903377

negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway

15790595

HgenePARK7

GO:1905259

negative regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway

14752510

HgenePARK7

GO:2000157

negative regulation of ubiquitin-specific protease activity

21097510



check button Four levels of functional features of fusion genes
Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr1:8022935/chr1:1749314)
- FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels.
- How to search
1. Put your fusion gene symbol.
2. Press the tab key until there will be shown the breakpoint information filled.
4. Go down and press 'Search' tab twice.
4. Go down to have the hyperlink of the search result.
5. Click the hyperlink.
6. See the FGviewer result for your fusion gene.
FGviewer

check buttonRetention analysis results of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features, are available here.

check buttonFusion gene breakpoints across PARK7 (5'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure

check buttonFusion gene breakpoints across GNB1 (3'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure


Top

Fusion Amino Acid Sequences


check buttonFusion information from ORFfinder translation from full-length transcript sequence from FusionPDB.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandSeq length
(transcript)
BP loci
(transcript)
Predicted start
(transcript)
Predicted stop
(transcript)
Seq length
(amino acids)
ENST00000338639PARK7chr18022935+ENST00000378609GNB1chr11749314-29832441541209351
ENST00000493678PARK7chr18022935+ENST00000378609GNB1chr11749314-2896157671122351
ENST00000377493PARK7chr18022935+ENST00000378609GNB1chr11749314-2887148581113351
ENST00000377491PARK7chr18022935+ENST00000378609GNB1chr11749314-30403012111266351
ENST00000377488PARK7chr18022935+ENST00000378609GNB1chr11749314-29852461561211351

check buttonDeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandNo-coding scoreCoding score
ENST00000338639ENST00000378609PARK7chr18022935+GNB1chr11749314-0.002400960.99759907
ENST00000493678ENST00000378609PARK7chr18022935+GNB1chr11749314-0.0025024610.9974975
ENST00000377493ENST00000378609PARK7chr18022935+GNB1chr11749314-0.0024105590.99758947
ENST00000377491ENST00000378609PARK7chr18022935+GNB1chr11749314-0.0027512230.9972487
ENST00000377488ENST00000378609PARK7chr18022935+GNB1chr11749314-0.0025672510.99743277

check button Predicted full-length fusion amino acid sequences. For individual full-length fusion transcript sequence from FusionPDB, we ran ORFfinder and chose the longest ORF among all the predicted ones.

Get the fusion protein sequences from here.

Fusion protein sequence information is available in the fasta format.
>FusionGDB ID_FusionGDB isoform ID_FGname_Hgene_Hchr_Hbp_Henst_Tgene_Tchr_Tbp_Tenst_length(fusion AA) seq_BP

Top

Fusion Protein Breakpoint Sequences for PARK7-GNB1

check button +/-13 AA sequence from the breakpoints of the fusion protein sequences.
HgeneHchrHbpTgeneTchrTbpLength(fusion protein)BP in fusion proteinPeptide
PARK7chr18022935GNB1chr1174931414830ETVIPVDVMRRAGDARKACADATLSQ
PARK7chr18022935GNB1chr1174931415730ETVIPVDVMRRAGDARKACADATLSQ
PARK7chr18022935GNB1chr1174931424430ETVIPVDVMRRAGDARKACADATLSQ
PARK7chr18022935GNB1chr1174931424630ETVIPVDVMRRAGDARKACADATLSQ
PARK7chr18022935GNB1chr1174931430130ETVIPVDVMRRAGDARKACADATLSQ

Top

Potential FusionNeoAntigen Information of PARK7-GNB1 in HLA I

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.

check button Potential FusionNeoAntigen Information
* We used NetMHCpan v4.1 (%rank<0.5) and deepHLApan v1.1 (immunogenic score>0.5)
Fusion geneHchrHbpTgeneTchrTbpHLA IFusionNeoAntigen peptideBinding scoreImmunogenic scoreNeoantigen start (at BP 13)Neoantigen end (at BP 13)

Top

Potential FusionNeoAntigen Information of PARK7-GNB1 in HLA II

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
PARK7-GNB1_8022935_1749314.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCIIpan v4.1 (%rank<0.5).
Fusion geneHchrHbpTgeneTchrTbpHLA IIFusionNeoAntigen peptideNeoantigen start (at BP 13)Neoantigen end (at BP 13)
PARK7-GNB1chr18022935chr11749314244DRB1-0801VIPVDVMRRAGDARK217
PARK7-GNB1chr18022935chr11749314244DRB1-0801TVIPVDVMRRAGDAR116
PARK7-GNB1chr18022935chr11749314244DRB1-0805VIPVDVMRRAGDARK217
PARK7-GNB1chr18022935chr11749314244DRB1-0805TVIPVDVMRRAGDAR116
PARK7-GNB1chr18022935chr11749314244DRB1-0806VIPVDVMRRAGDARK217
PARK7-GNB1chr18022935chr11749314244DRB1-0806TVIPVDVMRRAGDAR116
PARK7-GNB1chr18022935chr11749314244DRB1-0806IPVDVMRRAGDARKA318
PARK7-GNB1chr18022935chr11749314244DRB1-0806ETVIPVDVMRRAGDA015
PARK7-GNB1chr18022935chr11749314244DRB1-0810VIPVDVMRRAGDARK217
PARK7-GNB1chr18022935chr11749314244DRB1-0810TVIPVDVMRRAGDAR116
PARK7-GNB1chr18022935chr11749314244DRB1-0812VIPVDVMRRAGDARK217
PARK7-GNB1chr18022935chr11749314244DRB1-0812TVIPVDVMRRAGDAR116
PARK7-GNB1chr18022935chr11749314244DRB1-0816VIPVDVMRRAGDARK217
PARK7-GNB1chr18022935chr11749314244DRB1-0816TVIPVDVMRRAGDAR116
PARK7-GNB1chr18022935chr11749314244DRB1-0818VIPVDVMRRAGDARK217
PARK7-GNB1chr18022935chr11749314244DRB1-0820VIPVDVMRRAGDARK217
PARK7-GNB1chr18022935chr11749314244DRB1-0822VIPVDVMRRAGDARK217
PARK7-GNB1chr18022935chr11749314244DRB1-0822TVIPVDVMRRAGDAR116
PARK7-GNB1chr18022935chr11749314244DRB1-0822IPVDVMRRAGDARKA318
PARK7-GNB1chr18022935chr11749314244DRB1-0822ETVIPVDVMRRAGDA015
PARK7-GNB1chr18022935chr11749314244DRB1-0826VIPVDVMRRAGDARK217
PARK7-GNB1chr18022935chr11749314244DRB1-0826TVIPVDVMRRAGDAR116
PARK7-GNB1chr18022935chr11749314244DRB1-0831VIPVDVMRRAGDARK217
PARK7-GNB1chr18022935chr11749314244DRB1-0839VIPVDVMRRAGDARK217
PARK7-GNB1chr18022935chr11749314244DRB1-0839TVIPVDVMRRAGDAR116
PARK7-GNB1chr18022935chr11749314244DRB1-0840VIPVDVMRRAGDARK217
PARK7-GNB1chr18022935chr11749314244DRB1-1104VIPVDVMRRAGDARK217
PARK7-GNB1chr18022935chr11749314244DRB1-1106VIPVDVMRRAGDARK217
PARK7-GNB1chr18022935chr11749314244DRB1-1118VIPVDVMRRAGDARK217
PARK7-GNB1chr18022935chr11749314244DRB1-1125VIPVDVMRRAGDARK217
PARK7-GNB1chr18022935chr11749314244DRB1-1135VIPVDVMRRAGDARK217
PARK7-GNB1chr18022935chr11749314244DRB1-1138VIPVDVMRRAGDARK217
PARK7-GNB1chr18022935chr11749314244DRB1-1142VIPVDVMRRAGDARK217
PARK7-GNB1chr18022935chr11749314244DRB1-1143VIPVDVMRRAGDARK217
PARK7-GNB1chr18022935chr11749314244DRB1-1144VIPVDVMRRAGDARK217
PARK7-GNB1chr18022935chr11749314244DRB1-1146VIPVDVMRRAGDARK217
PARK7-GNB1chr18022935chr11749314244DRB1-1147VIPVDVMRRAGDARK217
PARK7-GNB1chr18022935chr11749314244DRB1-1150VIPVDVMRRAGDARK217
PARK7-GNB1chr18022935chr11749314244DRB1-1154VIPVDVMRRAGDARK217
PARK7-GNB1chr18022935chr11749314244DRB1-1154TVIPVDVMRRAGDAR116
PARK7-GNB1chr18022935chr11749314244DRB1-1156VIPVDVMRRAGDARK217
PARK7-GNB1chr18022935chr11749314244DRB1-1157VIPVDVMRRAGDARK217
PARK7-GNB1chr18022935chr11749314244DRB1-1158VIPVDVMRRAGDARK217
PARK7-GNB1chr18022935chr11749314244DRB1-1160VIPVDVMRRAGDARK217
PARK7-GNB1chr18022935chr11749314244DRB1-1177VIPVDVMRRAGDARK217
PARK7-GNB1chr18022935chr11749314244DRB1-1178VIPVDVMRRAGDARK217
PARK7-GNB1chr18022935chr11749314244DRB1-1183VIPVDVMRRAGDARK217
PARK7-GNB1chr18022935chr11749314244DRB1-1184VIPVDVMRRAGDARK217
PARK7-GNB1chr18022935chr11749314244DRB1-1188VIPVDVMRRAGDARK217
PARK7-GNB1chr18022935chr11749314244DRB1-1303VIPVDVMRRAGDARK217
PARK7-GNB1chr18022935chr11749314244DRB1-1304VIPVDVMRRAGDARK217
PARK7-GNB1chr18022935chr11749314244DRB1-1306VIPVDVMRRAGDARK217
PARK7-GNB1chr18022935chr11749314244DRB1-1311VIPVDVMRRAGDARK217
PARK7-GNB1chr18022935chr11749314244DRB1-1312VIPVDVMRRAGDARK217
PARK7-GNB1chr18022935chr11749314244DRB1-1312TVIPVDVMRRAGDAR116
PARK7-GNB1chr18022935chr11749314244DRB1-1313VIPVDVMRRAGDARK217
PARK7-GNB1chr18022935chr11749314244DRB1-1318VIPVDVMRRAGDARK217
PARK7-GNB1chr18022935chr11749314244DRB1-1321VIPVDVMRRAGDARK217
PARK7-GNB1chr18022935chr11749314244DRB1-1321TVIPVDVMRRAGDAR116
PARK7-GNB1chr18022935chr11749314244DRB1-1321IPVDVMRRAGDARKA318
PARK7-GNB1chr18022935chr11749314244DRB1-1321ETVIPVDVMRRAGDA015
PARK7-GNB1chr18022935chr11749314244DRB1-1330VIPVDVMRRAGDARK217
PARK7-GNB1chr18022935chr11749314244DRB1-1330TVIPVDVMRRAGDAR116
PARK7-GNB1chr18022935chr11749314244DRB1-1332VIPVDVMRRAGDARK217
PARK7-GNB1chr18022935chr11749314244DRB1-1332TVIPVDVMRRAGDAR116
PARK7-GNB1chr18022935chr11749314244DRB1-1342VIPVDVMRRAGDARK217
PARK7-GNB1chr18022935chr11749314244DRB1-1348VIPVDVMRRAGDARK217
PARK7-GNB1chr18022935chr11749314244DRB1-1348TVIPVDVMRRAGDAR116
PARK7-GNB1chr18022935chr11749314244DRB1-1349VIPVDVMRRAGDARK217
PARK7-GNB1chr18022935chr11749314244DRB1-1349TVIPVDVMRRAGDAR116
PARK7-GNB1chr18022935chr11749314244DRB1-1355VIPVDVMRRAGDARK217
PARK7-GNB1chr18022935chr11749314244DRB1-1355TVIPVDVMRRAGDAR116
PARK7-GNB1chr18022935chr11749314244DRB1-1355IPVDVMRRAGDARKA318
PARK7-GNB1chr18022935chr11749314244DRB1-1358VIPVDVMRRAGDARK217
PARK7-GNB1chr18022935chr11749314244DRB1-1358TVIPVDVMRRAGDAR116
PARK7-GNB1chr18022935chr11749314244DRB1-1358ETVIPVDVMRRAGDA015
PARK7-GNB1chr18022935chr11749314244DRB1-1358IPVDVMRRAGDARKA318
PARK7-GNB1chr18022935chr11749314244DRB1-1375VIPVDVMRRAGDARK217
PARK7-GNB1chr18022935chr11749314244DRB1-1375TVIPVDVMRRAGDAR116
PARK7-GNB1chr18022935chr11749314244DRB1-1381VIPVDVMRRAGDARK217
PARK7-GNB1chr18022935chr11749314244DRB1-1381TVIPVDVMRRAGDAR116
PARK7-GNB1chr18022935chr11749314244DRB1-1381IPVDVMRRAGDARKA318
PARK7-GNB1chr18022935chr11749314244DRB1-1381ETVIPVDVMRRAGDA015
PARK7-GNB1chr18022935chr11749314244DRB1-1388VIPVDVMRRAGDARK217
PARK7-GNB1chr18022935chr11749314244DRB1-1389VIPVDVMRRAGDARK217
PARK7-GNB1chr18022935chr11749314244DRB1-1389TVIPVDVMRRAGDAR116
PARK7-GNB1chr18022935chr11749314244DRB1-1389IPVDVMRRAGDARKA318
PARK7-GNB1chr18022935chr11749314244DRB1-1389ETVIPVDVMRRAGDA015
PARK7-GNB1chr18022935chr11749314244DRB1-1390VIPVDVMRRAGDARK217
PARK7-GNB1chr18022935chr11749314244DRB1-1393VIPVDVMRRAGDARK217
PARK7-GNB1chr18022935chr11749314244DRB1-1394VIPVDVMRRAGDARK217
PARK7-GNB1chr18022935chr11749314244DRB1-1395VIPVDVMRRAGDARK217
PARK7-GNB1chr18022935chr11749314244DRB1-1422VIPVDVMRRAGDARK217
PARK7-GNB1chr18022935chr11749314244DRB1-1425VIPVDVMRRAGDARK217
PARK7-GNB1chr18022935chr11749314244DRB1-1453VIPVDVMRRAGDARK217
PARK7-GNB1chr18022935chr11749314244DRB1-1463VIPVDVMRRAGDARK217
PARK7-GNB1chr18022935chr11749314244DRB1-1473VIPVDVMRRAGDARK217
PARK7-GNB1chr18022935chr11749314244DRB1-1474VIPVDVMRRAGDARK217
PARK7-GNB1chr18022935chr11749314244DRB1-1474TVIPVDVMRRAGDAR116
PARK7-GNB1chr18022935chr11749314244DRB1-1478VIPVDVMRRAGDARK217
PARK7-GNB1chr18022935chr11749314244DRB1-1478TVIPVDVMRRAGDAR116
PARK7-GNB1chr18022935chr11749314244DRB1-1478IPVDVMRRAGDARKA318
PARK7-GNB1chr18022935chr11749314244DRB1-1478ETVIPVDVMRRAGDA015
PARK7-GNB1chr18022935chr11749314244DRB1-1484VIPVDVMRRAGDARK217
PARK7-GNB1chr18022935chr11749314244DRB1-1485VIPVDVMRRAGDARK217

Top

Fusion breakpoint peptide structures of PARK7-GNB1

check button3D structures of the fusion breakpoint peptide of 14AA sequence that have potential fusion neoantigens
* The minimum length of the amino acid sequence in RoseTTAFold is 14AA. Here, we predicted the 14AA fusion protein breakpoint sequence not the fusion neoantigen peptide, which is shorter than 14 AA.

Top

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D of PARK7-GNB1

check buttonVirtual screening between 25 HLAs (from PDB) and FusionNeoAntigens
* We used Glide to predict the interaction between HLAs and neoantigens.
HLA allelePDB IDFile nameBPseqDocking scoreGlide score

Top

Vaccine Design for the FusionNeoAntigens of PARK7-GNB1

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-Is.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptide sequenceFusionNeoAntigen RNA sequence

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-IIs.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptideFusionNEoAntigen RNA sequence
PARK7-GNB1chr18022935chr11749314015ETVIPVDVMRRAGDAGAGACGGTCATCCCTGTAGATGTCATGAGGCGAGCTGGGGACGCC
PARK7-GNB1chr18022935chr11749314116TVIPVDVMRRAGDARACGGTCATCCCTGTAGATGTCATGAGGCGAGCTGGGGACGCCAGG
PARK7-GNB1chr18022935chr11749314217VIPVDVMRRAGDARKGTCATCCCTGTAGATGTCATGAGGCGAGCTGGGGACGCCAGGAAA
PARK7-GNB1chr18022935chr11749314318IPVDVMRRAGDARKAATCCCTGTAGATGTCATGAGGCGAGCTGGGGACGCCAGGAAAGCA

Top

Information of the samples that have these potential fusion neoantigens of PARK7-GNB1

check button These samples were reported as having these fusion breakpoints. For individual breakpoints, we checked the open reading frames considering multiple gene isoforms and chose the in-frame fusion genes only. Then, we made fusion protein sequences and predicted the fusion neoantigens. These fusion-positive samples may have these potential fusion neoantigens.
Cancer typeFusion geneHchrHbpHenstTchrTbpTenstSample

Top

Potential target of CAR-T therapy development for PARK7-GNB1

check button Predicted 3D structure. We used RoseTTAFold.

check buttonRetention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, to provide the retention of the transmembrane domain, we only show the protein feature retention information of those transmembrane features


* Minus value of BPloci means that the break point is located before the CDS.
- In-frame and retained 'Transmembrane'.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenProtein featureProtein feature note

check button Subcellular localization prediction of the transmembrane domain retained fusion proteins
* We used DeepLoc 1.0. The order of the X-axis of the barplot is as follows: Entry_ID, Localization, Type, Nucleus, Cytoplasm, Extracellular, Mitochondrion, Cell_membrane, Endoplasmic_reticulum, Plastid, Golgi.apparatus, Lysosome.Vacuole, Peroxisome. Y-axis is the output score of DeepLoc. Clicking the image will open a new tab with a large image.
HgeneHchrHbpHenstTgeneTchrTbpTenstDeepLoc result

Top

Related Drugs to PARK7-GNB1

check button Drugs used for this fusion-positive patient.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDrugSourcePMID

Top

Related Diseases to PARK7-GNB1

check button Diseases that have this fusion gene.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDiseaseSourcePMID

check button Diseases associated with fusion partners.
(DisGeNet 4.0)
PartnerGeneDisease IDDisease name# pubmedsSource